Top Tweets for #CompassPathways
$DFTX — Valye Company Analysis #psychedelicmedicine #CompassPathways #MindMed #AtaiLifeSciences
Definium Therapeutics is pursuing FDA approval for its lead psychedelic therapy DT120, which has demonstrated significant Phase 2b and early Phase 3 efficacy in generalized anxiety disorder. [S1] [S2] [N4] [N5]
Key points:
• DT120, Definium’s lead candidate for anxiety and depression, showed positive Phase 2b and Phase 3 interim results and holds FDA breakthrough therapy designation. [S1] [N4] [N5]
• Phase 3 readouts for DT120 in generalized anxiety disorder and major depressive disorder are expected in 2026, representing critical inflection points for the company. [S1] [N4] [N5]
• DT402, a proprietary R(-)-MDMA compound, is in early Phase 2a trials for autism spectrum disorder, broadening the pipeline’s potential addressable market. [S1]
• As of Q3 2026, Definium holds over $1 billion in current assets against $67.7 million in current liabilities, providing a substantialreported liquidity position for ongoing R&D. [S2]
• The company remains unprofitable, reporting a Q3 2026 net loss of $50.96 million, highlighting the need for eventual commercial success to offset continuing operating expenses. [S2]
📈 $CMPS Premarket +8.7%
COMPASS Pathways plc
Prev close: $13.80 → Now: $15.00
Market cap: $2.1B · Volume: 5.0M
Premarket moves are highly volatile. DYOR.
#CMPS #COMPASSPathways #Stocks #Trading
$SPRC — Valye Company Analysis #psychedelicmedicine #MindMed #CompassPathways #Cybin
SciSparc Ltd., through its majority-owned subsidiary NeuroThera, has advanced intellectual property combining MDMA with N-acylethanolamines targeting PTSD treatment, marking a strategic expansion into psychedelic drug innovation. This devel
Key points:
• NeuroThera, SciSparc's majority-owned subsidiary, has advanced MDMA combined with N-acylethanolamines intellectual property for PTSD treatment as of August 2026.
• This IP advancement coincides with increased U.S. federal support and FDA guidance for psychedelic drug innovation, potentially easing regulatory challenges.
• SciSparc's lead cannabinoid pharmaceutical candidate SCI-110 is in Phase IIb clinical trials for Tourette Syndrome and Alzheimer's disease agitation, following positive earlier-phase results.
• The company generates modest revenues from its nutraceutical segment, selling hemp seed oil-based products under the Wellution™ brand via Amazon Marketplace.
• SciSparc’s pharmaceutical segment currently produces no revenue and requires significant ongoing R&D investment, reflecting a capital-intensive development model.
Compass Pathways sigue reconstruyendo su tendencia tras una recuperación espectacular desde mínimos. La resistencia de 16-17 dólares será la gran prueba. 📈 #CompassPathways #Trading #WallStreet #MarketsBets $CMPS
#Australia je prvý štát na svete, ktorý schválil psychadeliká na liečbu duševného zdravia - posttraumatickej stresovej poruchy a depresie.
#CompassPathways PLC je verejne obchodovateľná spoločnosť, ktorá je najďalej so svojim výskumom.
#investicie , $CMPS
https://t.co/5X0708me4O
Compass Pathways and the potential of psychedelics-based treatments represent a significant development in the field of mental health research. It will be exciting to see how these treatments could impact the lives of millions of people. 💪🧠 #CompassPathways #psychedelics
Check out our summary of this paper with additional info here:
https://t.co/xlFja5NmAF
#psilocybin #compasspathways #clinicaltrial #psychedelicscience #depression #yourbrainonscience
We got some supplemental materials related to the #COMPASSpathways study on #psilocybin !! We wanted to share some extra info that wasn't in the podcast:
Largest clinical trial studying #psilocybin for #depression, had nearly a third of patients with severe depression go into rapid remission after a single dose of psilocybin followed by #therapy sessions. #compasspathways @ProfDavidNutt @guardian https://t.co/hFtE4FF5FC
Die Ergebnisse der #Psilocybin Studie von #CompassPathways sind ernüchternd. Nur die höchste Dosis von 25 Milligramm hilft Depression-Patienten und das auch nur in knapp 30 Prozent der Fälle. Trotzdem plant das Unternehmen eine Phase-III-Studie. https://t.co/69y43AmYXX
The largest psilocybin trial to date published in NEJM - congrats @COMPASSPathway - another level! https://t.co/jKOGMWp3Iy #compasspathways #Psilocybin
$CMPS in Uptrend: price expected to rise as it breaks its lower Bollinger Band on April 26, 2022. View odds for this and other indicators: https://t.co/rgUT7pKTVu #COMPASSPathways
$CMPS 10-Q Compass Pathways (10 May, 6:37am)
📊 2022 Q1 Earnings
https://t.co/5B0Hyv7ws1
#CMPS #10Q #CompassPathways #Earnings
Rally COMING for Q1? $MNMD $MMED $CMPS $BTC $ETH Bitcoin, Shroom Stocks all FALL! What's Next? #Mindmed #CompassPathways #Crypto https://t.co/w9HXr9Hx9b
PA Psilocybin Bill Could Make The State A Frontrunner In Psychedelic Research, Aiding Vets & First Responders https://t.co/4d4rSgYRpr #Cannabis #CompassPathways
How would you go about raising 300 million pounds?
Ekaterina Malievskaia faced this challenge while bringing her mental health treatment to market.
Did she succeed?
Listen here: https://t.co/eYO8qsV5gR
🤝 Supported by @OpenUniversity
#COMPASSPathways
We’ve compiled five companies that have recently gone public in the psychedelic arena to keep an eye on. Read the full list here. https://t.co/7QcmwzYqC8
@fieldtriphealth @HavnLife @NuminusInc @mindmedco #CompassPathways
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.3M followers
Barack Obama
@barackobama
118.8M followers
Cristiano Ronaldo
@cristiano
114.5M followers
Donald J. Trump
@realdonaldtrump
111.9M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.4M followers
Kim Kardashian
@kimkardashian
70.8M followers
YouTube
@youtube
68.7M followers
Neymar Jr
@neymarjr
66.4M followers
Bill Gates
@billgates
65.2M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.7M followers
X
@x
60.6M followers